How can recombinant adeno-associated virus (rAAV) vector technology be empowered with biofabrication strategies in its translation towards the clinic?
Publication date
2023-04
Authors
de Ruijter, Mylène
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Rheumatology, Biomedical Engineering, Orthopedics and Sports Medicine
Citation
de Ruijter, M 2023, 'How can recombinant adeno-associated virus (rAAV) vector technology be empowered with biofabrication strategies in its translation towards the clinic?', Osteoarthritis and Cartilage, vol. 31, no. 4, pp. 421-422. https://doi.org/10.1016/j.joca.2022.12.005